Please ensure Javascript is enabled for purposes of website accessibility

3 China Profit Plays

By Tim Hanson – Updated Apr 6, 2017 at 12:45AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The obvious ways to make money in the world's most important emerging market.

If you're like most U.S. investors I meet, you want to invest in China, but you don't know how. You also fret about the quality of corporate governance, a lack of internal controls, and loose enforcement of accounting standards.

So you've decided that despite the incredible long-term growth opportunity it offers, China is not worth the hassle. Either that or you settled for an index fund like the Xinhua 25 Index (NYSE:FXI).

Let's be frank: Neither of these solutions is a good one. But if you read to the end of this article, I guarantee that you'll be a little more comfortable with investing in China, and more importantly, you'll know three key niches where you should be looking to buy stocks.

But first, why you don't want FXI
The problem with the FXI is that it owns 25 enormous, mature, and generally state-owned Chinese companies such as China Mobile (NYSE:CHL). Thus, they're highly regulated, have little room to grow, and aren't run by executives who are known for their entrepreneurial spirit. Buying these stocks in the hopes of profiting from China's development would be like buying Pfizer (NYSE:PFE), Merck (NYSE:MRK), and GlaxoSmithKline (NYSE:GSK) in the hopes of profiting from a breakthrough cancer or AIDS drug.

Sure, you could end up making a little money, but you'd be better off finding the specific biotechs that are focused on the project.

Further, fully one-third of FXI is exposed to Chinese banks. These banks, as directed by the government in order to stimulate the Chinese economy, loaned out more money in the first four months of 2009 than in all of 2008. It's difficult to see growth like that and not conclude that underwriting standards were compromised, which could lead to significant profit hits down the line.

Thus, FXI is the wrong choice when it comes to investing in China. But the good news for you is that I have three far more promising alternatives.

China Profit Play No. 1: Rural China
The Chinese government, if nothing else, is focused on self-preservation. That means keeping most of their people content most of the time. And since most Chinese are still rural Chinese, recent government policies have focused on keeping them content amid the current economic downturn. These have recently included raising the minimum purchasing prices for rice, wheat, and soybeans, as well as introducing a new national health-care plan to strengthen the social safety net.

Thus far, these measures are working. The government expects rural incomes in China to rise 6% this year. That optimism has been corroborated by recent results from fertilizer companies such as China Green Agriculture (AMEX:CGA) and Yongye Biotechnology that have topped all expectations due in part to farmers' increasing purchasing power. At Motley Fool Global Gains, we expect these companies and others that sell directly into rural China to continue to post good results.

China Profit Play No. 2: Tier 2 Infrastructure
Quick! Name a city in China!

Chances are you said Beijing or Shanghai, and not Xian, Harbin, or Tianjin despite the fact that all five have populations in the multimillions. That's because while the former are world-famous tier 1 cities in China, the latter are relatively unknown tier 2 cities. But in order to even out development in China, the government has made building infrastructure in these tier 2 cities and making them attractive places to do business a priority. For tier 2, this means more roads, power plants, subways, etc.

But rather than pick a company that builds subways or coal-fired power plants or roads or nuclear power plants, at Global Gains we like companies that work across these niches. That's something like China Fire & Security (NASDAQ:CFSG), which supplies fire detection and extinguishing systems for use in power plants, subways, tunnels, and more.

China Profit Play No. 3: SSE-led Consolidation
The fact is that while China's economy has been growing at a near-10% annual rate for the past 25 years, growth is slowing and the low-hanging fruit when it comes to spurring growth has long since been plucked from the tree. Thus, the government is focused on ways to make the economy ever more efficient. One of the strategies they've hit on is the forced consolidation of small, inefficient state-owned enterprises (SOEs) under private companies that they can count on to do right by workers and wring inefficiency out of operations.

We discovered some of these "chosen few" in the health-care and steel sectors during our last research trip to China, and we dubbed them SSEs, or state-sponsored entrepreneurs. We're keen to invest alongside them because of their good relations with the government and their advantaged position when it comes to acquiring new assets, products, or distribution capacity.

Take the next step
This article has provided you with a few leads on how to make real money from China's growth, but if you're ready for more, I invite you to sign up and join us as our Global Gains research team travels back to China in July to meet with more than a dozen promising companies.

By providing your email address below, you'll receive all of our real-time analysis from the road absolutely free.

Tim Hanson is co-advisor of Motley Fool Global Gains. This will be his third trip to China. You can follow Global Gains' Twitter feed here. Tim owns shares of China Fire & Security and Yongye Biotechnology. China Green Agriculture is a Global Gains recommendation, while China Fire & Security Group is a former selection. Pfizer is an Inside Value pick. The Fool's disclosure policy is on the lookout for beef jerky profit plays and will let you know when it finds one.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Merck & Co., Inc. Stock Quote
Merck & Co., Inc.
MRK
$86.18 (-0.69%) $0.60
Pfizer Inc. Stock Quote
Pfizer Inc.
PFE
$43.83 (-0.57%) $0.25
China Mobile Limited Stock Quote
China Mobile Limited
CHL
GSK Stock Quote
GSK
GSK
$28.82 (-1.84%) $0.54
iShares Trust - iShares China Large-Cap ETF Stock Quote
iShares Trust - iShares China Large-Cap ETF
FXI
$26.77 (0.60%) $0.16
China Green Agriculture, Inc. Stock Quote
China Green Agriculture, Inc.
CGA
$6.40 (-7.61%) $0.53

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.